NASDAQ · Conglomerates · USD

Harte Hanks, Inc. (HHS) Stock Analysis

Harte Hanks, Inc. (HHS) is a Conglomerates stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

HHS

$3.96

−$0.22 (−5.26%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare HHS with… →

HHS Key Statistics

As of Oct 21, 2026

Trading

Open: $4.19
Previous Close: $4.18
Day's Range: 3.92–4.22
52-Week Range: 2.00–4.67
Volume: 182.90K
Beta: 0.17

Valuation

Market Cap: $29.52M
P/E Ratio: unprofitable
P/S ratio: 0.19
EPS (ttm): −0.77

Financials (FY)

Revenue (FY): $159.57M−13.86%
Net Income (FY): −$811.00K
Profit margin: −3.70%
Shares Outstanding: 7.45M
1-Year Return: +10.61%

Dividend and dates

Avg Volume: 163.07K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, HHS closed at $3.96, +10.61% over 1 year.

Harte Hanks, Inc. (HHS) has a market capitalization of $29.52M.

In fiscal 2025, HHS reported revenue of $159.57M.

HHS Stock Return by Calendar Year

Harte Hanks, Inc. (HHS) 10-year return: what $10,000 became

1 year: $10,000 $11,061; +10.61%
5 years: $10,000 $5,485; −45.15%
10 years: $10,000 $2,640; −73.60%

If you had invested $10,000 in Harte Hanks, Inc. (HHS) 10 years ago, at the close on October 21, 2016, it would have been worth $2,640 at the close on October 21, 2026: −73.60% in total, −12.47% a year. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

−74.53%+176.36%+31.56%

2016*2017201820192020202120222023202420252026*

Year	Return
2026 (partial year)	+31.56%
2025	−41.55%
2024	−24.15%
2023	−41.92%
2022	+53.82%
2021	+176.36%
2020	−23.18%
2019	+47.93%
2018	−74.53%
2017	−37.09%
2016 (partial year)	−12.72%

As of October 21, 2026.

HHS Revenue and Earnings by Fiscal Year

FY ends December

RevenueNet income

2022202320242025

Fiscal year	Revenue	Net income	Net margin
2025	$159.57M	−$811.00K	−0.5%
2024	$185.24M	−$30.30M	−16.4%
2023	$191.49M	−$1.57M	−0.8%
2022	$206.28M	$36.78M	17.8%

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$159.57M	$109.67M	$2.17M	−$811.00K	−0.5%
2024	$185.24M	$128.60M	$7.66M	−$30.30M	−16.4%
2023	$191.49M	$131.92M	$9.05M	−$1.57M	−0.8%
2022	$206.28M	$144.35M	$15.11M	$36.78M	17.8%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

HHS Valuation vs Conglomerates Median

Median of 28 stocks

Metric	HHS	Conglomerates median	vs median
P/S ratio	0.19	0.71	0.3x the median
Profit margin	−3.70%	2.23%	5.9 pts below

Medians across 28 Conglomerates stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Harte Hanks, Inc. (HHS) is capitalised at $29.52M on the latest close. It is classified in the Conglomerates industry, within the Industrials sector. Headcount on file is 1,719.

Over the past 52 weeks the price has ranged from $2.00 to $4.67. The most recent close on file for HHS is $3.96, dated October 21, 2026. That is −$0.22 (−5.26%) against the previous close. The latest close sits 98% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $159.57M. Against the prior fiscal year total of $185.24M, that is a change of −13.86%. The same year closed with a net loss of $811.00K. Profit margin runs at −3.7%. That is 5.9 percentage points below the Conglomerates median of 2.23%. Earnings per share on a trailing basis come to −0.77.

Across the 4 fiscal years on file, revenue moves from $206.28M in 2022 to $159.57M in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. Measured against sales, the shares trade at 0.19 times revenue. On price-to-sales that is 0.3 times the Conglomerates median of 0.71. 28 Conglomerates companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at 0.17. Annualized volatility over the trailing 10 years is 65.29%. Over the trailing twelve months the total return is +10.61%. Measured over 10 years, that is −12.47% a year compounded.

Growth & Income

The record shows no dividend for HHS.

2026 is still running; the total return is +31.56% year to date. Across the complete calendar years on file, 2021 returned +176.36% and 2018 returned −74.53%. Of the 9 complete calendar years on file, 3 finished higher.

Peer Comparison

Harte Hanks, Inc. (HHS) operates in the Conglomerates industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Harte Hanks, Inc.	HHS	$29.52M	—
3M Company	MMM	$90.12B	26.1
Honeywell International Inc.	HON	$68.06B	7.9
Valmont Industries, Inc.	VMI	$8.66B	17.5

The Conglomerates industry average P/E ratio is 9.9x. Harte Hanks, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Conglomerates Stocks

MMM

3M Company

$90.12B

HON

Honeywell International Inc.

$68.06B

VMI

Valmont Industries, Inc.

$8.66B

BBUC

Brookfield Business Corporation

$5.49B

GHC

Graham Holdings Company

$5.18B

PAM

Pampa Energía S.A.

$4.18B

View all Conglomerates stocks →

Popular Industrials Stocks

SPCX

Space Exploration Technologies Corp.

$2.10T

CAT

Caterpillar Inc.

$335.91B

GE Aerospace

$306.99B

RTX

RTX Corporation

$258.23B

GEV

GE Vernova Inc.

$246.60B

View all Industrials stocks →

About Harte Hanks, Inc.

Harte Hanks, Inc. operates as a customer experience company in the United States and internationally. It operates through three segments: Revenue Solutions, Customer Care, and Fulfillment and Logistics. It offers data and analytics, including audience identification, profiling, segmentation and prioritization, and predictive modeling and data strategy; research and intelligence, helps in understanding of customers, category, competitors, and capabilities; strategy, which plans and executes omnichannel marketing, demand generation, and customer experience programs; creative and content, including creative concepts, messaging and content assets for print, broadcast, direct mail, website, app, display, social, mobile, search engine marketing, and voice; marketing technology, a website and app development, e-commerce development and enablement, database building and management, platform architecture creation, and marketing automation; digital and multi-channel marketing execution and advertising; demand generation and account based marketing; and managed marketing services. It also provides product, print-on-demand, and mail fulfillment services, including as printing on demand and distributing literature, managing product recalls, and promotional and branded product distribution; and third-party logistics and freight optimization services. In addition, the company offers inside sales outsourcing, which provides B2B enterprises, and small to midsized businesses with an outsourced sales service; lead generation services; and sales play development, as well as customer service outsourcing, customer care technology and artificial intelligence transformation, and self-service technology. It serves B2B, healthcare, pharmaceuticals, health insurance, consumer, travel, hospitality, streaming, entertainment, quick service restaurants, financial, fintech, automotive, and retail industries. The company was founded in 1923 and is headquartered in Chelmsford, Massachusetts.

Visit website →